secwatch.observer — SEC 8-K summary
======================================

Issuer:     STAAR SURGICAL CO (STAA)
CIK:        0000718937
Form:       8-K
Filed at:   2025-05-16T23:59:59+00:00
Accession:  0000950170-25-073099
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STAAR Surgical announces $30M buyback and China NMPA approval for EVO+ TICL
---------------------------------------------------------------------------

- Authorized $30M share repurchase program, expected to run over six months from cash on hand.
- Company had $222.8M cash and equivalents, no debt as of March 28, 2025; ~49.5M shares outstanding.
- China's NMPA approved EVO+ Toric ICL for myopia correction (-0.5D to -18D, astigmatism ≤6D).
- EVO+ spheric ICL application remains pending with NMPA; Switzerland manufacturing validations ongoing for China supply.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/718937/000095017025073099/0000950170-25-073099-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/718937/000095017025073099/staa-20250516.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-073099

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer